Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Abbott India
Join Channel
Consolidated Standalone

Abbott India

₹26863.3 493.3 | 1.9%

Market Cap ₹57083 Cr.

Stock P/E 47.6

P/B 15.4

Current Price ₹26863.3

Book Value ₹ 1740.7

Face Value 10

52W High ₹29628.2

Dividend Yield 1.53%

52W Low ₹ 20594.3

Edit Ratio

Abbott India Research see more...

Overview Inc. Year: 1944Industry: Pharmaceuticals & Drugs

Abbott India Ltd is a healthcare company engaged in pharmaceuticals enterprise. The Company has a portfolio of technology-based offerings in diagnostics, medical devices, nutritional and branded well-known pharmaceuticals. Its commercial enterprise operations are divided into four commercial enterprise divisions: Women's Health & Gastrointestinal, Gastroenterology and Hepatic Care; Speciality Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestinal, Gastroenterology and Hepatic Care division has a combination of internationaal and local brands present inside the pregnancy, constipation and liver diseases segments. The Speciality Care department includes various merchandise within the treatment of central nervous system and metabolic problems. The GenNext department focuses on several remedy areas, inclusive of pain management, nutrients and pregnancy. Its vaccines comprises Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present inside the over-the-counter antacid segment.

Read More..

Abbott India Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Abbott India Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 1224 1255 1304 1379 1322 1343 1479 1494 1437 1439
Other Income 19 21 27 34 44 50 56 56 56 81
Total Income 1243 1276 1331 1413 1366 1393 1535 1550 1493 1520
Total Expenditure 955 961 1034 1036 1010 1063 1124 1113 1049 1109
Operating Profit 288 315 297 377 356 330 411 436 443 411
Interest 4 5 4 4 4 4 3 3 3 3
Depreciation 17 17 17 17 18 17 17 18 18 18
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 267 292 275 355 335 308 390 415 422 390
Provision for Tax 67 81 70 90 88 77 100 102 111 103
Profit After Tax 199 211 206 266 247 231 290 313 311 287
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 199 211 206 266 247 231 290 313 311 287
Adjusted Earnings Per Share 93.7 99.5 96.8 125 116.2 108.9 136.6 147.3 146.3 135.1

Abbott India Profit & Loss

#(Fig in Cr.) Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1653 2276 2289 2615 2903 3299 3679 4093 4310 4913 5349 5849
Other Income 23 49 48 51 60 118 114 115 83 83 154 249
Total Income 1675 2325 2338 2666 2963 3417 3793 4208 4393 4997 5503 6098
Total Expenditure 1451 2009 1978 2251 2508 2775 3075 3337 3391 3832 4143 4395
Operating Profit 224 317 360 415 455 641 718 871 1002 1165 1360 1701
Interest 0 0 1 3 2 4 2 9 18 19 16 12
Depreciation 19 22 15 14 16 16 17 60 58 66 70 71
Exceptional Income / Expenses 10 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 215 295 344 398 436 621 699 803 926 1080 1274 1617
Provision for Tax 70 96 115 143 160 220 249 210 235 281 324 416
Profit After Tax 145 198 229 255 277 401 450 593 691 799 949 1201
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 145 198 229 255 277 401 450 593 691 799 949 1201
Adjusted Earnings Per Share 68.1 93.4 107.7 120.1 130.2 188.8 211.9 279 325 375.9 446.8 565.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 9% 10% 12%
Operating Profit CAGR 17% 16% 16% 20%
PAT CAGR 19% 17% 19% 21%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 27% 19% 30% 32%
ROE Average 32% 30% 28% 27%
ROCE Average 43% 40% 39% 39%

Abbott India Balance Sheet

#(Fig in Cr.) Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 647 788 938 1196 1387 1693 2009 2432 2602 2820 3189
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 31 443 432 29 35 41 62 210 190 184 144
Total Current Liabilities 502 652 834 382 632 668 857 891 1031 1203 1206
Total Liabilities 1179 1883 2204 1607 2053 2402 2928 3532 3823 4207 4539
Fixed Assets 109 98 96 108 110 81 105 270 251 271 237
Other Non-Current Assets 25 442 445 48 51 55 62 58 84 83 1277
Total Current Assets 1046 1343 1663 1451 1893 2231 2761 3205 3487 3853 3025
Total Assets 1179 1883 2204 1607 2053 2402 2928 3532 3823 4207 4539

Abbott India Cash Flow

#(Fig in Cr.) Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 109 109 79 49 140 202 38 137 145 218 133
Cash Flow from Operating Activities 101 155 215 249 307 153 499 626 727 948 893
Cash Flow from Investing Activities -59 -144 -187 -77 -155 -215 -257 -401 -72 -396 -148
Cash Flow from Financing Activities -42 -42 -58 -80 -90 -102 -143 -217 -582 -637 -639
Net Cash Inflow / Outflow 1 -31 -30 91 62 -165 99 8 73 -86 107
Closing Cash & Cash Equivalent 109 79 49 140 202 38 137 145 218 133 240

Abbott India Ratios

# Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 68.1 93.39 107.75 120.12 130.19 188.81 211.93 279.03 325.03 375.86 446.78
CEPS(Rs) 77.27 103.71 114.78 126.92 137.92 196.43 219.89 307.08 352.39 406.96 479.71
DPS(Rs) 17 23 31 35 40 55 65 250 275 275 325
Book NAV/Share(Rs) 304.41 370.77 441.2 562.65 646.43 786.76 932.19 1127.5 1203.71 1306.18 1480.48
Core EBITDA Margin(%) 12.03 11.58 13.44 13.75 13.43 15.83 16.42 18.47 20.56 21.51 21.96
EBIT Margin(%) 12.84 12.76 14.88 15.14 14.92 18.91 19.06 19.82 21.12 21.86 23.5
Pre Tax Margin(%) 12.84 12.76 14.86 15.04 14.85 18.79 19 19.61 20.71 21.48 23.2
PAT Margin (%) 8.64 8.59 9.88 9.65 9.41 12.13 12.24 14.49 15.45 15.89 17.29
Cash Profit Margin (%) 9.8 9.54 10.53 10.19 9.97 12.62 12.7 15.94 16.75 17.2 18.57
ROA(%) 11.41 12.96 11.2 13.39 15.12 18.01 16.9 18.36 18.78 19.89 21.71
ROE(%) 24.3 27.66 26.54 23.93 21.54 26.35 24.66 27.09 27.89 29.95 32.07
ROCE(%) 36.11 41.07 39.98 37.55 33.96 40.61 37.88 36.54 37.52 40.53 42.93
Receivable days 29.82 19.78 18.77 18.91 19.95 24.26 26.77 26.49 23.19 19.54 20.12
Inventory Days 56.51 49.21 58.54 52.03 54.07 59.93 59.14 50.56 50.82 51.02 44.44
Payable days 41.6 33.37 45.79 51.74 75.01 91.74 99.97 104.13 108.42 113.47 109.28
PER(x) 21.81 18.77 36.64 39.19 35.63 28.86 34.43 55.39 46.11 47.09 49.43
Price/Book(x) 4.88 4.73 8.95 8.37 7.18 6.93 7.83 13.71 12.45 13.55 14.92
Dividend Yield(%) 1.14 1.31 0.79 0.74 0.86 1.01 0.89 1.62 1.83 1.55 1.47
EV/Net Sales(x) 1.71 1.43 3.38 3.5 3.02 3.2 3.76 7.49 6.83 7.1 8.41
EV/Core EBITDA(x) 12.64 10.3 21.53 22.08 19.27 16.44 19.25 35.19 29.37 29.93 33.09
Net Sales Growth(%) 10.9 37.71 0.59 14.2 11.02 13.64 11.52 11.27 5.3 14 8.86
EBIT Growth(%) 19.33 37.03 17.05 16.14 9.49 42.59 12.12 15.71 16.39 16.37 17.38
PAT Growth(%) 20.19 37.15 15.37 11.48 8.38 45.03 12.24 31.67 16.49 15.64 18.87
EPS Growth(%) 20.19 37.15 15.37 11.48 8.38 45.03 12.24 31.66 16.49 15.64 18.87
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.08 2.06 1.99 3.79 3 3.34 3.22 3.6 3.38 3.2 2.51
Quick Ratio(x) 1.56 1.51 1.53 2.83 2.2 2.46 2.51 3 2.69 2.63 1.97
Interest Cover(x) 8996.52 3532.82 685.07 158.63 215.33 163.6 311.82 95.1 51.65 57.53 80.66
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Abbott India Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
FII 0.22 0.22 0.2 0.2 0.2 0.19 0.19 0.18 0.18 0.18
DII 6.76 7.52 7.95 7.86 8.39 8.62 8.78 8.83 8.74 8.91
Public 18.04 17.27 16.86 16.95 16.42 16.21 16.05 16 16.1 15.93
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 30%
  • Debtor days have improved from 113.47 to 109.28days.
  • Company is almost debt free.

Cons

  • Stock is trading at 15.4 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Abbott India News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!